Intra-Cellular Therapies Inc [ITCI] Records 200-Day SMA of $61.92

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Intra-Cellular Therapies Inc shares valued at $1,341,123 were sold by Mates Sharon on Mar 11 ’24. At $65.21 per share, Mates Sharon sold 20,565 shares. The insider’s holdings dropped to 1,050,309 shares worth approximately […]

Robert W. Baird initates Intra-Cellular Therapies Inc (ITCI) rating to an Outperform

In a filing, Intra-Cellular Therapies Inc revealed its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $69.19 million. Then, Hineline Lawrence […]

Analysts review Intra-Cellular Therapies Inc’s rating

Intra-Cellular Therapies Inc’s filing revealed that its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $71.88 million. Then, Hineline Lawrence J. […]

Sharp decrease in ITCI’s short interest leads to decline in days-to-cover ratio

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Intra-Cellular Therapies Inc shares valued at $1,341,123 were sold by Mates Sharon on Mar 11 ’24. At $65.21 per share, Mates Sharon sold 20,565 shares. The insider’s holdings dropped to 1,050,309 […]

Checking in on Intra-Cellular Therapies Inc (ITCI) after recent insiders movement

Intra-Cellular Therapies Inc’s recent filing unveils that its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $72.68 million. Then, Hineline Lawrence […]

Intra-Cellular Therapies Inc (ITCI) receives an Outperform rating from Robert W. Baird

In a filing, Intra-Cellular Therapies Inc revealed its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $72.49 million. Then, Hineline Lawrence […]